뒤로
Clover Biopharmaceuticals, Ltd.(02197.HK) 가격
02197.HK 주가 차트
CLOVER BIO-B (02197.HK)
Clover Biopharmaceuticals, Ltd.
HK$2.55
-1.54%
$-0.04
정규장: Jan 19, 13:30:02 HKT
주요 통계
이전 종가
$2.59
시가
$2.59
일일 범위
$2.48 - $2.59
52주 범위
$0.185 - $3.18
거래량
1.0M
평균 거래량
10.9M
EPS(TTM)
-0.80
배당수익률
--
시가총액
$3.3B
CLOVER BIO-B란 무엇인가요?
Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 243 full-time employees. The company went IPO on 2021-11-05. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The firm leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The firm conducts its business in the domestic and overseas markets.
